Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
Anna Maisa(Burnet Institute), Sandra Dudareva(Robert Koch Institute), Stefan Mauss(Center for HIV and Hepatogastroenterology), Daniel Schmidt(Robert Koch Institute), Matthias an der Heiden(Robert Koch Institute), Christian Kollan(Robert Koch Institute), Florian van Bömmel(University Hospital Leipzig), Heiner Wedemeyer(Medizinische Hochschule Hannover), Markus Cornberg(Medizinische Hochschule Hannover)
Cited by 3
Related Papers
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718